Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2462 Views
-
Last post by NHE
-
- 0 Replies
- 1128 Views
-
Last post by frodo
-
- 0 Replies
- 1079 Views
-
Last post by NHE
-
- 0 Replies
- 1271 Views
-
Last post by frodo
-
- 0 Replies
- 1393 Views
-
Last post by NHE
-
- 0 Replies
- 1141 Views
-
Last post by frodo
-
- 0 Replies
- 2465 Views
-
Last post by NHE
-
- 0 Replies
- 1462 Views
-
Last post by NHE
-
- 0 Replies
- 1707 Views
-
Last post by DIM